Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Godaddy Inc (GDDY) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

Godaddy IncTrade
Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Godaddy Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Godaddy Inc trades at $104.53 (market cap $13.07B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.79 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Godaddy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Godaddy Inc for 65 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.

GDDYRPRX
Market Cap
$13.07B$25.27B
Volume
1,831,2743,671,183
Sector
TechnologyHealth
52-Week High
$135.18$63.96
52-Week Low
$75.07$35.44
Typical Hold Time
65 Days0 Days
Enterprise Value
$15.75B$32.50B
Dividend Yield
—1.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Godaddy Inc

GoDaddy (GDDY) trades at $97.21, down 0.99% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company shows strong profitability with 63.8% gross margins and has beaten earnings estimates for three consecutive quarters. Revenue growth continues steadily from $4.95B in 2025 to projected $5.1B in 2026. Analyst consensus remains positive with 57.9% buy ratings and a $96.20 price target, though the stock faces headwinds from multiple securities class action lawsuits alleging misleading disclosures about domain pricing strategies.

The outlook remains cautiously optimistic given strong fundamentals and earnings momentum, but legal risks from ongoing securities litigation present significant near-term uncertainty. Investors should weigh the company's solid operational performance against potential legal liabilities and stock price volatility stemming from the class action proceedings with October 2026 deadlines.

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GDDY
1% Buy99% Sell
Avg holding period · 65 Days
RPRX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Godaddy Inc

GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.

Read more on GDDY →

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →